Metabolic Disorders in Chronic Lung Diseases
Open Access
- 18 January 2018
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 4, 246
Abstract
Chronic lung diseases represent complex diseases with gradually increasing incidence, characterized by significant medical and financial burden for both patients and relatives. Their increasing incidence and complexity render a comprehensive, multidisciplinary, and personalized approach critically important. This approach includes the assessment of comorbid conditions including metabolic dysfunctions. Several lines of evidence show that metabolic comorbidities, including diabetes mellitus, dyslipidemia, osteoporosis, vitamin D deficiency, and thyroid dysfunction have a significant impact on symptoms, quality of life, management, economic burden, and disease mortality. Most recently, novel pathogenetic pathways and potential therapeutic targets have been identified through large-scale studies of metabolites, called metabolomics. This review article aims to summarize the current state of knowledge on the prevalence of metabolic comorbidities in chronic lung diseases, highlight their impact on disease clinical course, delineate mechanistic links, and report future perspectives on the role of metabolites as disease modifiers and therapeutic targets.Keywords
This publication has 131 references indexed in Scilit:
- The Hallmarks of AgingCell, 2013
- Severe and uncontrolled adult asthma is associated with vitamin D insufficiency and deficiencyRespiratory Research, 2013
- Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary FibrosisNew England Journal of Medicine, 2012
- Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphonyCardiovascular Diabetology, 2012
- Delayed Access and Survival in Idiopathic Pulmonary Fibrosis: A Cohort StudyAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Pilot analysis of the plasma metabolite profiles associated with emphysematous Chronic Obstructive Pulmonary Disease phenotypeBiochemical and Biophysical Research Communications, 2011
- A Concise Review of Pulmonary SarcoidosisAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Metabolic Abnormalities in Children with AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthmaOsteoporosis International, 2009
- Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEuropean Respiratory Journal, 2008